Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
Cartilage degeneration is a key feature of aging and osteoarthritis, characterized by the progressive deterioration of joint function, pain, and limited mobility. Current treatments focus on symptom relief, not cartilage regeneration. Mesenchymal stromal cells (MSCs) offer a promising therapeutic option due to their capability to differentiate into chondrocytes, modulate inflammation, and promote tissue regeneration. This review explores the potential of MSCs for cartilage regeneration, examining their biological properties, action mechanisms, and applications in preclinical and clinical settings. MSCs derived from bone marrow, adipose tissue, and other sources can self-renew and differentiate into multiple cell types. In aging cartilage, they aid in tissue regeneration by secreting growth factors and cytokines that enhance repair and modulate immune responses. Recent preclinical studies show that MSCs can restore cartilage integrity, reduce inflammation, and improve joint function, although clinical translation remains challenging due to limitations such as cell viability, scalability, and regulatory concerns. Advancements in MSC delivery, including scaffold-based approaches and engineered exosomes, may improve therapeutic effectiveness. Potential risks, such as tumorigenicity and immune rejection, are also discussed, emphasizing the need for optimized treatment protocols and large-scale clinical trials to develop effective, minimally invasive therapies for cartilage regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MSC-based therapies demonstrate superior potential in cartilage repair and osteoarthritis, yet high costs and regulatory barriers hinder clinical adoption [125,126].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [125]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [125]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Schwarzl, T., Keogh, A., Shaw, G., Krstić, A., Clayton, E., Murphy, M., Higgins, D. G., Kölch, W., & Barry, F. (2023) · Scientific Data · doi:10.1038/s41597-023-02686-y · Cited by 15 · cited 1×
“Bone marrow-derived MSCs (BM-MSCs) are the most extensively studied and show strong potential for differentiating into chondrocytes, making them a common choice for cartilage regeneration [23,24].”
Shaz, B. H., Schäfer, R., Fontaine, M. J., Norris, P. J., McKenna, D. H., Jin, P., Reems, J., Stroncek, D. F., Tanashi, M., Marks, D. C., et al. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.11.003 · Cited by 15 · cited 1×
“Shaz et al. found that local manufacturing processes contribute to variability in MSC expansion, while growth media supplements affect gene expression and cell function [107].”
Chen, X., Foote, A. G., & Thibeault, S. L. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.08.016 · Cited by 14 · cited 1×
“Maintaining cell density below 2 × 10 7 cells/mL and DMSO concentration below 0.5% can help preserve viability above 82% when using 25-or 27-gauge needles [112].”
InfluentialSoufihasanabad, S., Mahmoudi, M., Taghavi-Farahabadi, M., Mirsanei, Z., Lamouki, R. M., Abdalla, J. K. M., Babaei, E., & Hashemi, S. M. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111353 · Cited by 14 · cited 1×
“They also promote macrophage polarization from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, further mitigating inflammatory responses [42,43].”
Chang, Y., Ding, D., & Wu, K. (2021) · Stem Cells International · doi:10.1155/2021/2989054 · Cited by 13 · cited 4×
“Derived from tissues, such as bone marrow, adipose tissue, and umbilical cord blood, MSCs possess the ability for self-renewal and multipotency, making them ideal candidates for repairing damaged cartilage [17,18].”
InfluentialSelf-citationChang, Y., Wu, K., & Ding, D. (2022) · Biomedicines · doi:10.3390/biomedicines10112773 · Cited by 13 · cited 3×
“Derived from tissues, such as bone marrow, adipose tissue, and umbilical cord blood, MSCs possess the ability for self-renewal and multipotency, making them ideal candidates for repairing damaged cartilage [17,18].”
Self-citationAkatsu, Y., Enomoto, T., Yamaguchi, S., Tahara, M., Fukawa, T., Endo, J., Hoshi, H., Yamamoto, Y., Sasaki, T., Takahashi, K., et al. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2914-y · Cited by 12
Enhancement of mesenchymal stem cells’ chondrogenic potential by type II collagen-based bioscaffolds
Piperigkou, Z., Bainantzou, D., Makri, N., Papachristou, E., Mantsou, A., Choli‐Papadopoulou, T., Theocharis, A. D., & Karamanos, N. K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08461-x · Cited by 12 · cited 1×
“Once differentiated, MSC-derived chondrocytes produce essential ECM components, including collagen type II and aggrecan, which are crucial for the structural integrity and functionality of healthy cartilage [48,49].”
Carneiro, P., de Freitas, M. V., & Matte, Ú. D. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262299 · Cited by 11 · cited 1×
“Population-specific analysis of potential off-target sites is crucial, as polymorphisms can affect cleavage likelihood and create new PAM sequences [156].”
Enzyme-controlled, nutritive hydrogel for mesenchymal stromal cell survival and paracrine functions
Denoeud, C., Luo, G., Paquet, J., Boisselier, J., Wosinski, P., Moya, A., Diallo, A., Larochette, N., Marinesco, S., Meiller, A., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05643-y · Cited by 11 · cited 1×
“To address this challenge, researchers have developed glucose-releasing scaffolds and enzyme-controlled, nutritive hydrogels that provide physiological glucose levels to MSCs [73].”
Mesenchymal Stem Cell Engineering
Liu, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8802-0_15 · Cited by 10 · cited 3×
“Continued research in MSC engineering and chondrogenic differentiation is crucial for advancing cartilage tissue engineering and developing effective treatments for joint diseases [145,146].”
Type II Collagen-Conjugated Mesenchymal Stem Cells Micromass for Articular Tissue Targeting
Sulaiman, S., Chowdhury, S. R., Fauzi, M. B., Rani, R. A., Yahaya, N. H. M., Tabata, Y., Hiraoka, Y., Idrus, R. B. H., & Ng, M. H. (2021) · Biomedicines · doi:10.3390/biomedicines9080880 · Cited by 10 · cited 1×
“Once differentiated, MSC-derived chondrocytes produce essential ECM components, including collagen type II and aggrecan, which are crucial for the structural integrity and functionality of healthy cartilage [48,49].”
Heterogeneity of mesenchymal stem cells: characterization and application in cell therapy
Liu, X., Zhao, Z., Zhao, Z., Xu, Z., Cao, J., Wang, B., & Suo, G. (2022) · STEMedicine · doi:10.37175/stemedicine.v3i1.109 · Cited by 10 · cited 1×
“To address this issue, researchers have explored marker-based isolation strategies to purify MSC subpopulations [101,218].”
Akkawi, I., Draghetti, M., & Zmerly, H. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i1.11102 · Cited by 9 · cited 2×
“MSCs have shown promise in treating OA due to their regenerative and anti-inflammatory properties [210].”
Singh, N., Bhattacharjee, A., Kumar, P., & Katti, D. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122212 · Cited by 9 · cited 1×
“Another study found that combining tissue inhibitors of metalloproteinase-3, sulfated carboxymethylcellulose, and piperlongumine synergistically reduced inflammation, cartilage matrix loss, chondrosenescence, and oxidative stress in ex vivo OA models [186].”
Advanced clinical imaging for the evaluation of stem cell based therapies
Klontzas, M. E., Kakkos, G. A., Papadakis, G. Z., Marias, K., & Karantanas, A. H. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1890711 · Cited by 8 · cited 1×
“Advanced imaging techniques, including diffusion-weighted MRI and contrast-enhanced ultrasound, show promise for stem cell treatment evaluation [189].”
Kaonis, S., Aboellail, Z., Forman, J., & Ghosh, S. (2023) · Advanced Biology · doi:10.1002/adbi.202300318 · Cited by 8 · cited 1×
“This heterogeneity is influenced by microenvironmental factors, including mechanical stiffness, which can alter MSC gene expression and commitment [103].”
Galocha-León, C., Clares, B., & Gálvez‐Martín, P. (2018) · Current Pharmaceutical Analysis · doi:10.2174/1573412913666170613090734 · Cited by 7 · cited 2×
“Various analytical techniques, such as membrane integrity assays, morphological studies, and fluorescence biosensors, are used to assess MSC viability [109].”
Regenerative Effect of Mesenchymal Stem Cell on Cartilage Damage in a Porcine Model
Lin, S.-C., Panthi, S., Hsuuw, Y.-H., Chen, S.-H., Huang, M., Sieber, M. A., & Hsuuw, Y.-D. (2023) · Biomedicines · doi:10.3390/biomedicines11071810 · Cited by 7
Self-citationComparison of clinical outcomes between total hip replacement and total knee replacement
Green, A., Walsh, A., & Al‐Dadah, O. (2023) · World Journal of Orthopedics · doi:10.5312/wjo.v14.i12.853 · Cited by 7 · cited 1×
“When conservative therapies fail and OA severely affects daily life, total joint replacement, particularly of the knee or hip, is often the preferred intervention [14].”
Fares, M. Y., Shehadeh, T. H., Daher, M., Boufadel, P., Koa, J., & Abboud, J. A. (2024) · Acta Orthopaedica Belgica · doi:10.52628/90.2.12364 · Cited by 7 · cited 1×
“Various MSC sources, including umbilical cord blood and autologous or allogeneic cells, have been investigated [94,95].”
Kraus, V. B., & Hsueh, M.-F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00022-8 · Cited by 5 · cited 1×
“Biomarkers play a crucial role in identifying early-stage OA and predicting disease progression, enabling more effective personalized treatments [193].”
Wu, J.-L., Wong, P., Ho, C.-W., Chen, C.-H., Liao, K.-Y., Lovel, R., Wu, T. B., Chang, W., Lee, Y.-Z., & Lin, W. (2021) · Applied Sciences · doi:10.3390/app11146650 · Cited by 5 · cited 1×
“Human umbilical cord MSCs combined with hyaluronic acid showed synergistic effects in ameliorating knee OA progression in rats [177].”
Spasovski, D., Spasovski, V., Baščarević, Z., Stojiljković, M., Andjelković, M., & Pavlović, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133861 · Cited by 5 · cited 1×
“A 7-year follow-up study demonstrated long-term clinical benefits and improved cartilage structure after a single injection of adipose-derived MSCs in knee OA patients [158].”
Calcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P. A., O’Brien, T., Taylor, A., & Bieback, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.14.507944 · Cited by 3 · cited 2×
“Immunophenotyping con fi rmed typical MSC surface markers across sources, with slight variations in Immunophenotyping confirmed typical MSC surface markers across sources, with slight variations in quantitative data between laboratories [34]. quantitative data between laboratories ].”
Prithiviraj, S., Garcia, A. G., Linderfalk, K., Yiguang, B., Ferveur, S., Falck, L. N., Subramaniam, A., Mohlin, S., Hidalgo, D., Dupard, S. J., et al. (2025) · eLife · doi:10.1101/2023.07.28.550935 · Cited by 2
Salerno, A., Rikkers, M., Brady, K., & Hollander, A. P. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.02.789 · Cited by 1 · cited 1×
“However, with extensive passaging, chondrogenic potency eventually declines, despite the retention of trophic repair properties [204].”
Alonso-Camino, V., & Mirsch, B. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.03.099 · Cited by 1 · cited 1×
“Alonso-Camino & Mirsch emphasized the importance of uniform protocols for MSCs from different sources to improve result comparability and clinical translation [220].”
Cited by
Mesenchymal stem cell-derived exosomes: A paradigm shift in clinical therapeutics
Chattopadhyay, S., Rajendran, R. L., Chatterjee, G., Reyaz, D., Prakash, K., Hong, C. M., Ahn, B., ArulJothi, K. N., & Gangadaran, P. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114616 · Cited by 31
Goulian, A. J., Goldstein, B., & Saad, M. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062061 · Cited by 25
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
Nonaka, T., Murata, D., Yoshizato, H., Kashimoto, S., Nakamura, A., Morimoto, T., & Nakayama, K. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05604-7 · Cited by 16
“Therefore, cartilage constructs with an appropriate thickness are difficult to fabricate [24].”
The role of synovial mesenchymal stem cell-derived exosomes in cartilage repair: a systematic review
Su, J., Qi, Y., Niu, L., Wang, Y., Wei, B., Ma, B., Kong, K., Zhai, Z., & Xu, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1617874 · Cited by 13
“Irreversible changes in knee joint structure: exosomes are unable to directly repair osteophytes or reconstruct severely worn cartilage layers, but may reduce pain and in fl ammation by regulating the remaining subchondral bone to talk to the synovium (Wu et al., 2024).”
Coleman, L. J., Byrne, J. L., Edwards, S., & O’Hara, R. (2025) · Biologics · doi:10.3390/biologics5030027 · Cited by 15
“More recent advances include hydrogels, gene therapy, and stem cell-based approaches show promise, particularly mesenchymal stromal cells for their regenerative and anti-inflammatory properties, though delivery, safety, and scalability challenges persist [54,55].”
Metadata
- Authors
- Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z.
- Affiliations
- Tzu Chi University (TW)
- Corresponding author
- Ding, Dah-Ching
- Lin, Shinn-Zong
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-11-30
- Volume
- 25
- Issue
- 23
- Pages
- 12911
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC11641625
- OpenAlex
- W4404903366
- Cited by
- 33
- References
- 228
- Citations by year
- 2026: 22 · 2025: 11
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- NSTC (113-2314-B-303-024)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- mesenchymal stem cells, cartilage regeneration, osteoarthritis, cartilage degeneration, chondrogenic differentiation, growth factor secretion, inflammation modulation, bone marrow-derived MSCs, adipose-derived MSCs, exosomes, tumorigenicity, immune rejection, clinical translation
- MeSH terms
- Aging, Animals, Cartilage, Cartilage, Articular, Cell Differentiation, Humans, Osteoarthritis, Regeneration, Chondrocytes, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.